Healthspan podcast

94. Effects of Semaglutide on CKD in Patients with Type 2 Diabetes

07/10/2024
0:00
11:00
Reculer de 15 secondes
Avancer de 15 secondes

@ michaelsalzle Patients with diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. The FLOW trial looked at the safety and efficacy of semaglutide in patients with chronic disease and type 2 diabetes.

D'autres épisodes de "Healthspan"